. Jean Pierre Garnier

• Management
• Pharma & Biotech
• Switzerland

Johnson & Johnson to acquire all of the outstanding shares of Actelion for $280 per share payable in U.S. dollars

In the previous press release the companies omitted the cash amount with which R&D NewCo will launch. This has now…